首页> 外文期刊>Chromatographia >Selective solid phase extraction of a drug lead compound using molecularly imprinted polymers prepared by the target analogue approach
【24h】

Selective solid phase extraction of a drug lead compound using molecularly imprinted polymers prepared by the target analogue approach

机译:使用目标类似物方法制备的分子印迹聚合物对药物前导化合物进行选择性固相萃取

获取原文
获取原文并翻译 | 示例
           

摘要

Molecularly imprinted polymers have been evaluated at the sample clean-up stage in the analysis of a drug lead compound. In order to circumvent quantification problems related to bleeding of the template, a structurally related analogue of the latter was used. This was selected based on criteria related to interaction site location, solubility, availability and stability of the analogue. Selection of suitable polymerisation conditions was then made using a small batch format (ca. 50 mg) and rapid assessment of binding in the equilibrium mode. It was found that the amount of template could be greatly reduced compared to the conventional protocol, requiring only 5 mumol of template per gram of polymer without seriously compromising the performance of the materials for chromatographic or SPE applications. [References: 13]
机译:在药物前导化合物的分析中,已经在样品净化阶段对分子印迹聚合物进行了评估。为了规避与模板渗色有关的量化问题,使用了模板的结构相关类似物。根据与相互作用部位的位置,类似物的溶解度,可用性和稳定性有关的标准进行选择。然后使用小批量形式(约50 mg)选择合适的聚合条件,并以平衡模式快速评估结合。已经发现,与常规方案相比,模板的量可以大大减少,每克聚合物仅需要5μmol模板,而不会严重损害用于色谱或SPE应用的材料的性能。 [参考:13]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号